NeuMoDx CT/NG Assay designed to improve accessibility, affordability and timeliness in sexually transmitted infection (STI) testing in the U.S..
Sun Pharma to acquire Taro shares for $347.73m
Share this article Sun Pharma and Taro’s merger is anticipated to conclude in the first half of 2024. Credit: Nils Versemann / Shutterstock.com. Sun Pharmaceutical